These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


444 related items for PubMed ID: 16877988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 3. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 4. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [Abstract] [Full Text] [Related]

  • 5. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [Abstract] [Full Text] [Related]

  • 6. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T.
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.
    Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G, Pinzani M.
    Transl Res; 2010 Oct; 156(4):229-34. PubMed ID: 20875899
    [Abstract] [Full Text] [Related]

  • 13. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R.
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [Abstract] [Full Text] [Related]

  • 14. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [Abstract] [Full Text] [Related]

  • 15. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [Abstract] [Full Text] [Related]

  • 16. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.
    Acta Biochim Pol; 2011 Dec; 58(4):563-6. PubMed ID: 22140659
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K.
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [Abstract] [Full Text] [Related]

  • 19. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.